Intravenous magnesium sulfate administration reduces propofol infusion requirements during maintenance of propofol-N 2O anesthesia: Part I: Comparing propofol requirements according to hemodynamic responses. Part II: Comparing bispectral index in control and magnesium groups

Anesthesiology

Volumn 97, Issue 5, 2002, Pages 1137-1141

  Choi, Jae Chan ^a   Yoon, Kyung Bong ^a   Um, Dae Ja ^a   Kim, Chan ^b   Kim, Jin Soo ^b   Lee, Sang Gyu ^c  

^a Yonsei University Wonju   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE; NITROUS OXIDE; PROPOFOL; SODIUM CHLORIDE;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; BALANCED ANESTHESIA; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; FEMALE; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; INHALATION ANESTHESIA; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; STATISTICAL SIGNIFICANCE;

ADULT; ANESTHESIA; BLOOD PRESSURE; ELECTROENCEPHALOGRAPHY; FEMALE; HEART RATE; HUMANS; MAGNESIUM SULFATE; NITROUS OXIDE; PROPOFOL; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0036841112     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200211000-00017     Document Type: Article

References (27)

1. Nowak L. Bregestovski P, Ascher P, Herbet A, Prochiantz A: Magnesium gates glutamate activated channels in mouse central neurones. Nature 1984; 307:462-5
2. Harrison NL, Simmonds MA: Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol 1985; 84:381-91
3. Kroin JS, McCarthy RJ, Roenn NV, Schwab B, Tuman KJ, Ivankovich AD: Magnesium sulfate potentiates morphine antinociception at the spinal level. Anesth Analg 2000; 90:913-7
4. McCarthy RJ, Kroin JS, Tuman KJ, Penn RD, Ivankovich AD: Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats. Anesth Analg 1998; 86:830-6
5. Choi JC, Yoon KB, Kim JS, Kim SY, Lee KH, Lee YB, Lim HK, Jun ES: The potentiation of the analgesic effect of intrathecally coadministered magnesium sulphate and bupivacaine in duration of sensory blockade in rats. Korean J Anesthesiol 2001; 41:S33-8
6. Koinig H, Wallner T, Marhofer P, Andel H. Hörauf K, Mayer N: Magnesium sulfate reduces intra- and postoperative analgesic requirements. Anesth Analg 1998; 87:206-10
7. Tramèr MR, Schneider J, Marti RA, Rifat K: Role of magnesium sulfate in postoperative analgesia. Anesthesiology 1996; 84:340-7
8. Thompson SW, Moscicki JC, DiFazio CA: The anesthetic contribution of magnesium sulfate and ritodrine hydrochloride in rats. Anesth Analg 1988; 67:31-4
9. Hudspith MJ: Glutamate: A role in normal brain function, anaesthesia, analgesia and CNS injury. Br J Anaesth 1997; 78:731-47
10. Reves JG, Glass PSA, Lubarsky DA: Nonbarbiturate intravenous anesthetics, Anesthesia, 5th edition. Edited by Miller RD, Cucchiara RF, Miller RD Jr, Reves JG, Roizen MF, Savarese JJ. Philadephia, Churchill Livingstone, 2000, pp 228-72
11. Thurnau GR, Kemp DB, Jarvis A: Cerobrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: A preliminary report: Am J Obstet Gynecol 1987: 157:1435-8
12. Fuchs-Buder T. Tramèr, MR, Tassonyi E: Cerebrospinal fluid passage of intravenous magnesium sulfate in neurosurgical patients. J Neurosurg Anesthesiol 1997; 9:324-8
13. Sanchez-Capuchino A, McConachie I: Peri-operative effect of major gastrointestinal surgery on serum magnesium. Anaesthesia 1994; 49:912-4
14. Rygh LJ, Svendsen F, Hole K, Tjølsen A: Natural noxious stimulation can induce long-term increase of spinal nociceptive responses. Pain 1999; 82: 305-10
15. Svendsen F, Tjølsen A, Hole K: AMPA and NMDA receptor-dependent spinal LTP after nociceptive tetanic stimulation. Neuroreport 1998; 9:1185-90
16. Bromm B, Scharein E, Vahle-Hinz C: Cortex areas involved in the processing of normal and altered pain. Prog Brain Res 2000; 129:289-302
17. Beattie C: History and principles of anesthesiology, Goodman & Gilman's the Pharmacological Basis of Therapeutics, 10th Edition. Edited by Hardman JG, Limbird LE, Gilman AG. New York, McGraw-Hill, 2001, pp 321-35
18. Chizh BA, Dickenson AH, Wnendt S: The race to control pain: more participants, more targets. Trends Pharmacol Sci 1999; 20:354-6
19. Evers AS, Crowder CM: General anesthetics, Goodman & Gilman's the Pharmacological Basis of Therapeutics, 10th edition. Edited by Hardman JG, Limbird LE, Gilman AG. New York, McGraw-Hill, 2001, pp 337-65
20. Glass PS, Bloom M, Kearse L, Rosow C, Sebel P. Manberg P: Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology 1997; 86:836-47
21. Friedberg BL: The effect of a dissociative dose of ketamine on the bispectral index (BIS) during propofol hypnosis. J Clin Anesth 1999; 11:4-7
22. Rampil IJ, Kim JS, Lenhardt R, Negishi C, Sessler DI: Bispectral EEG index during nitrous oxide administration. Anesthesiology 1998; 89:671-7
23. Avramov MN, Badrinath S, Shadrick M, Ivankovich AD: The effect of ketamine on EEG-bispectral index (BIS) during propofol sedation. Anesthesiology 1997; 87:A501
24. Morioka N, Ozaki M, Matsukawa T, Sessler DI, Atarashi K, Suzuki H: Ketamine causes a paradoxical increase in the bispectral index. Anesthesiology 1997; 87:A502
25. Hirota K, Kubota T, Ishihara H, Matsuki A: The effects of nitrous oxide and ketamine on the bispectral index and 95% spectral edge frequency during propofol-fentanyl anaesthesia. Eur J Anaesthesiol 1999; 16:779-83
26. Sakai T, Singh H, Mi WD, Kudo T, Matsuki A: The effect of ketamine on clinical endpoints of hypnosis and EEG variables during propofol infusion. Acta Anaesthesiol Scand 1999; 43:212-6
27. Mroczek WJ, Lee WR, Davidov ME: Effect of magnesium sulfate on cardiovascular hemodynamics. Angiology 1977; 28:720-4